BAM
HARP

Bellevue Asset Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Bellevue Asset Management’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5
Closed -$1K – 660
2021
Q1 		$1K Hold
5
– – ﹤0.01% 636
2020
Q4 		$1K Buy
+5
New +$773 ﹤0.01% 638

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Bellevue Asset Management's HARP Position: Q2 2021 in Review

Bellevue Asset Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2021, closing a stake of 5 shares — an estimated $1K sold.

Bellevue Asset Management first reported a position in HARP in Q4 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2021. 85 funds tracked by Wall St. Rank hold HARP as of Q2 2021.

  • Bellevue Asset Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bellevue Asset Management sold 5 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $1K.
  • Bellevue Asset Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Bellevue Asset Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $1K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Bellevue Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.